Articles On Oventus Medical (ASX:OVN)

The ASX 200 managed to hold on to its lunchtime gains today, finishing the day higher by 0.43 per cent. Health care and Information Tech were the best and worst performing sectors respectively. Geospatial tech company Nearmap (ASX:NEA) rose...

Summary Digital health player ResApp Health has entered into a non-exclusive distribution agreement with Ilara Health. Recce Pharmaceuticals stated that RECCE® 327 had shown bactericidal activity against ESKAPE pathogens, including the...

Summary Medicinal cannabis player Botanix Pharmaceuticals Limited has provided a clinical development update of the BTX 1801 antimicrobial platform. Botanix’s BTX 1801 was safe, well-tolerated, clinically effective in the Phase 2a stud...

Summary Oventus Medical witnessed growth in booked revenue and acceleration in telehealth bookings in Q3 FY21. ECS Botanics Holdings’ March 2021 quarter was action-packed with a major acquisition and multiple supply agreements. Despit...

Source:Cryptographer, Shutterstock Summary Stem cell and regenerative medicine player Cynata Therapeutics will expand recruitment criteria for its active MEseNchymal coviD-19 clinical trial. Oventus medical enters into a virtual Lab i...

Source: wutzkohphoto, Shutterstock Summary Sleep Apnea treatment provider Oventus Medical enters into two new contracts for the sale and distribution of its devices. The Company said that the agreements show the flexibility and scalab...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

The Oventus Medical Ltd (ASX: OVN) share price moved higher today, jumping 7.32% to 22 cents a share at the time of writing. The Oventus share price was sent flying after the medical device company released its half-year results for the pe...

Summary Brisbane-based medical device company Oventus Medical updated its quarterly business review for Q2 FY21. The Company notified that the booked revenue from device sales, consumables, and service fees for the second quarter rose...

Peter Switzer speaks to the founder and CEO of Oventus (OVN), Dr Chris Hart.

Obstructive sleep apnea company Oventus Medical (ASX:OVN) has signed a marketing agreement with VGM & Associates.

ShareCafeHidden Gems Webinar Recap – NMT, EX1, DCC, OVN Catch up on the full webinar with presentations from Neometals, Exopharm, DigitalX and Oventus Medical. Hidden Gems Webinar Recap – NMT, EX1, DCC, OVNCompany News

ShareCafeOventus Medical – Hidden Gems Webinar Presentation   Presenter – Chris Hart – Founder – Oventus is a Brisbane-based medical device company that is commercialising a unique treatment platform for sleep apnoea and snoring. The Compa...

Bell Financial Group (ASX:BFG) is expecting to book a higher $23.5m first-half profit, but investors didn’t seem overly happy about it with shares dipping 5.2 per cent on Friday morning. The figure is 5 per cent up on the same period last y...

Optimism is returning to the sleep apnoea market as Somnomed (ASX:SOM) says the nightmares that prompted a $15.5m capital raising in March haven’t returned. In fact, “trading has been better than expected and forecast” since the company rai...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   This week’s big themes The ca...

Sleep apnoea device company Oventus Medical has kicked off a capital raising to help fund its growth in US markets. 

The main way for treating obstructive sleep apnoea (OSA) could be problematic during COVID-19, according to one small cap in the field. The first port of call for patients with OSA, which causes a person to stop breathing periodically and s...

Medical device company Oventus Medical (ASX: OVN) has confirmed its sleep treatment platform will be included in a range of obstructive sleep apnoea (OSA) treatment solutions being sold by Aeroflow Healthcare, a US durable medical equipment...

Medical device company Oventus Medical (ASX: OVN) has launched a further three clinical delivery sites in the US as part of its “lab in lab” business model while confirming that its initial five sites generated first revenues in December 20...

Sleep apnoea — or sleep suffocation as some have taken to calling it — is big business on the ASX, spanning billion-dollar ResMed (ASX:RMD) to a group of small caps. Oventus (ASX:OVN), one of those small caps, is the latest this month to ad...

The venerable sleep disorders house is starting to sound like a car maker that has exhausted the possible names for its variant models and is now relying on letters, dashes, errant capital letters and numbers. A case in point is ResMed’s (A...

The ASX enjoyed some fresh record highs today as Chinese trade data surpassed expectations ahead of the US-China trade deal signing. It was a strong night on Wall Street while we slept down under, with the NASDAQ and S&P 500 each hi...

Oventus Medical Limited (ASX: OVN) has signed two additional contracts in the US sleep market with clinics under which Oventus devices would be used for the treatment of patients diagnosed with Obstructive Sleep Apnoea (OSA). Highlights T...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Small cap stocks are the stocks of those enterprises that have a low market capitalisation. Estimated market capitalisation of small cap companies is between $300 million and $2 billion. Small cap stocks have several advantages such as the...

Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the stethoscope and picking up the microphone for a new segment. Say hello to The Health Kick Podcast. For his inaugural episode Tim interviews Chris Hart, founder,...

Did you know that on 23 September 1889 Nintendo was founded. The Japanese gaming company was created by entrepreneur Fusajiro Yamauchi as a card company called Nintendo Koppai, which was based in Kyoto. The company originally produced and s...

On Stockhead today, why Australia’s telco sector is “mission critical, Amazon finds spare change under couch cushion and orders 100,000 EVs and WA mining smashes employment and sales records. But first:   The day ahead The Reserve Bank of A...

One of the best in the world, Australian health care sector is unceasingly advancing technologies to deliver the best health care services. Despite, a few uncertainties, health care sector caught investors’ attention to invest in leading bi...

Medical devices company Oventus Medical (ASX: OVN) has received a major boost in its bid to see the O2Vent Optima oral device being sold across the US. Earlier today, Oventus announced that it had received regulatory clearance from the US F...

The market may have dropped lower today, but the same cannot be said for the LiveTiles Ltd (ASX: LVT) share price. In morning trade the intelligent workplace software provider’s shares have rocketed 12.5% higher to 40 cents. Why is the Liv...

The science of Regenerative Medicine is a rapidly emerging field linking the medical technology, biotechnology and pharmaceutical sectors, and holds much potential to deliver better patient outcomes and drive economic growth.  Regenerative...

The healthcare industry of Australia is a key contributor in developing the economy. The companies who are in this industry, have to update them with the new medicine for the treatment of the diseases. The healthcare space of Australia is p...

Pharmaxis, one of last year’s biggest small cap reporting season winners, has tumbled 412 per cent into the red as its fortunes fluctuate on the anti-inflammatory drug it sold to German pharma giant Boehringer Ingelheim four years ago. Afte...

A further two US sleep medicine groups have agreed to adopt Oventus Medical’s (ASX: OVN) O2Vent sleep technology to treat obstructive sleep apnoea at their facilities. Delaware Sleep Disorder Centres and Reliable Respiratory will roll-out O...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

In this piece of writing, we would discuss the three stocks from healthcare sector traded on the ASX. The Australian benchmark index S&P/ASX 200 closed at 6793.4, down by 24.60 points or 0.4% from the previous close, on 26 July 2019. Ov...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

Four stocks trading on ASX – Oventus Medical Limited, Codan Limited, Indoor Skydive Australia Group Limited and Objective Corporation Limited – started their trading session on 15 July 2019 with positive market updates. Let us have a broade...

Consumer tech business OpenDNA (ASX:OPN) has been manoeuvring for a while now to get distribution channels set up into China. And following a market announcement this morning, it looks like it will also have some products to sell in the sec...